Table of Contents

company-logo

Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in the infectious disease in Canada. Its anti-infective portfolio includes Favipiravir for pandemic influenza and COVID-19; ATI-2307, an antifungal candidate, which is in clinical stage for the treatment of cryptococcal meningitis and invasive candidiasis; ATI-1503 that develops a class of gram-negative targeting antibiotics; ATI-1501, a taste-masked liquid oral suspension formulation of an antibiotic, metronidazole; ATI-1801, a novel topical formulation of paromomycin for the treatment of cutaneous leishmaniasis; and ATI-1701 is a live-attenuated vaccine for Francisella tularensis. The company has a strategic alliance with AiPharma Global Holdings LLC for the development of Avigan/Reeqonus (favipiravir). Appili Therapeutics Inc. was incorporated in 2015 and is headquartered in Halifax, Canada.

Appili Therapeutics Dividend Announcement

• Appili Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Appili Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Appili Therapeutics Dividend History

Appili Therapeutics Dividend Yield

Appili Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Appili Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Appili Therapeutics Financial Ratios

P/E ratio-0.96
PEG ratio0.01
P/B ratio-0.35
ROE49.50%
Payout ratio0.00%
Current ratio0.16
Quick ratio0.16
Cash Ratio0.02

Appili Therapeutics Dividend FAQ

Does Appili Therapeutics stock pay dividends?
Appili Therapeutics does not currently pay dividends to its shareholders.
Has Appili Therapeutics ever paid a dividend?
No, Appili Therapeutics has no a history of paying dividends to its shareholders. Appili Therapeutics is not known for its dividend payments.
Why doesn't Appili Therapeutics pay dividends?
There are several potential reasons why Appili Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Appili Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Appili Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Appili Therapeutics a dividend aristocrat?
Appili Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Appili Therapeutics a dividend king?
Appili Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Appili Therapeutics a dividend stock?
No, Appili Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Appili Therapeutics stocks?
To buy Appili Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Appili Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.